Zenosense (OTC: ZENO), a healthcare technology company, this
morning announced that its MIDS Medical Ltd. (“MML”) joint venture (“JV”) has
entered a staged funding for the next phase of development of the MIDS Cardiac™
hand-held technology. MML entered into an agreement with a third-party investor
for funding of up to a total of $1,200,000 on August 31, 2018. The funding is
anticipated to cover the expenses of the next key development phase intended to
prove that the MIDS magnetic detection method can detect and accurately
quantify a live high sensitivity (“HS”) assay on the MIDS microfluidic test
strip. Per the agreement, MML will receive an initial total amount of $300,000
in exchange for ordinary shares in MML representing a 2.91% equity ownership,
with the option to make scheduled payments up to an additional $900,000. The
full $1,200,000 investment would result in a 10.31% equity ownership in MML.
To view the full press release, visit http://ibn.fm/4fRf0
About Zenosense, Inc.
Zenosense Inc., through a joint-venture ownership in MIDS
Medical Ltd., is primarily focused on the development of a cost-effective,
hand-held Point of Care rapid cardiac diagnostic device, MIDS Cardiac. MIDS
Medical applies patent-protected magnetic nanoparticle detection technology and
a development team with world-class technical expertise. The MIDS Cardiac
device and test strip is being designed to support a variety of rapid high
sensitivity cardiac biomarker tests, with a focus on troponin I and T, to
identify or discount Acute Myocardial Infarction with accuracy equal or
superior to high sensitivity assays performed on laboratory analyzers. For more
information, visit the company’s website at www.Zenosense.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is committed
to connecting subscribers with companies that have huge potential to succeed in
the short and long-term future. It is part of our mission statement to help the
investment community discover emerging companies that offer excellent growth
potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments:
Post a Comment